Congenital heart disease in England: a national cohort study from fetal diagnosis to end of infancy
Open Access
Abstract
Background Population studies of congenital heart disease (CHD) often include only children receiving cardiac interventions, underestimating the burden of cases without intervention. We evaluated outcomes for all detected structural CHD cases in England from fetal life to the age of 1 year. Method We linked the National Congenital Anomaly and Rare Disease Registration Service, the National Congenital Heart Disease Audit, and Office for National Statistics mortality records to construct an incident cohort with estimated delivery/birth dates 2018–2020. Outcomes were: termination of pregnancy, fetal loss (miscarriage/stillbirth), live birth with no cardiac intervention in infancy, and live birth with intervention(s) in infancy. Infant mortality at the age of 1 year was assessed. Results Among 11 265 CHD cases, 63.7% were antenatally detected (95% CI 62.8% to 64.6%), rising to 94.2% (92.0% to 96.0%) for hypoplastic left heart syndrome (HLHS). There were 1766 terminations (15.7%, 95% CI 14.7% to 16.7%), 295 fetal losses (2.6%, 95% CI 1.6% to 3.6%), 4538 live births with no infant cardiac intervention (40.3%, 95% CI 39.3% to 41.3%) and 4666 with intervention(s) (41.4%, 95% CI 40.4% to 42.4%). Termination was higher with greater CHD complexity (eg, HLHS 51.1% (95% CI 46.8% to 55.5%) versus isolated ventricular septal defect 6.0% (95% CI 4.3% to 7.7%), pConclusion This national, linked cohort shows that un-intervened cases account for most infant deaths and that antenatal detection exceeds 90% for the most complex lesions. Registries and quality improvement should include all CHD care pathways to inform counselling and equitable service planning.Keywords
Funding Information
- National Institute for Health and Care Research (PR-R20-0318-23001)
This publication has 22 references indexed in Scilit:
- Updated EUROCAT guidelines for classification of cases with congenital anomaliesBirth Defects Research, 2024
- Pregnancy Termination and Postnatal Major Congenital Heart Defect Prevalence After Introduction of Prenatal Cardiac ScreeningJAMA Network Open, 2023
- Pregnancy loss in major fetal congenital heart disease: incidence, risk factors and timingUltrasound in Obstetrics & Gynecology, 2023
- Prevalence of congenital heart defects in Europe, 2008–2015: A registry‐based studyBirth Defects Research, 2022
- Live-Born Major Congenital Heart Disease in DenmarkJAMA Cardiology, 2018
- Incorporating Comorbidity Within Risk Adjustment for UK Pediatric Cardiac SurgeryThe Annals of Thoracic Surgery, 2017
- Ethnic and socioeconomic variation in incidence of congenital heart defectsArchives of Disease in Childhood, 2016
- Neighbourhood Deprivation, Individual-Level and Familial-Level Socio-demographic Factors and Risk of Congenital Heart Disease: A Nationwide Study from SwedenInternational Journal of Behavioral Medicine, 2015
- Birth prevalence of congenital heart defects in Norway 1994-2009—A nationwide studyAmerican Heart Journal, 2014
- Female gender increases the risk of death during hospitalization for pediatric cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2007